BCG’s Torben Danger expects companies to prioritize innovation, reduce costs, improve productivity, and increase M&A activity this year.
Education
- PhD, law, University of Freiburg
- MA, law, University of Freiburg
Torben Danger is the global leader for Boston Consulting Group's Health Care practice, which encompasses biopharma, medical technologies, payers, providers, health systems, and global health.
Since joining BCG in 2005, Torben has centered his client work on strategy, sales and marketing, integration, transformation, and operations projects in the medical technology and biopharma industries.
Through his assignments across many health care segments and locations, Torben has developed a firsthand appreciation of how cost pressure, provider consolidation, and other trends such as digitization affect the industry.
